Gemcitabine Plus Cisplatin With or Without M7824 in Participants With 1L Biliary Tract Cancer (BTC)
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer Interventions: Drug: M7824; Drug: Placebo; Drug: Gemcitabine; Drug: Cisplatin Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Germany Health | Research